curative ventures
3
116M
3
0.21
1
3
- Stages of investment
- Areas of investment
Summary
The main department of described VC is located in the Dallas. The company was established in North America in United States.
Among the most popular portfolio startups of the fund, we may highlight ITeos Therapeutics, TCR2. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - Belgium. Among the most successful fund investment fields, there are Medical, Medical Device.
The standard case for the fund is to invest in rounds with more than 10 partakers. Despite the curative ventures, startups are often financed by The Column Group, Remeditex Ventures, UBS Asset Management. The meaningful sponsors for the fund in investment in the same round are MPM Capital, 6 Dimensions Capital, Vida Ventures.
The top amount of exits for fund were in 2019. The real fund results show that this VC is 13 percentage points more often commits exit comparing to other companies. This curative ventures works on 38 percentage points more the average amount of lead investments comparing to the other organizations. The important activity for fund was in 2018. The common things for fund are deals in the range of more than 100 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
Besides them, we counted 1 critical employee of this fund in our database.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 1
- Exits
- 3
- Rounds per year
- 0.21
- Investments by industry
- Biotechnology (3)
- Health Care (3)
- Medical (2)
- Therapeutics (2)
- Pharmaceutical (2) Show 2 more
- Investments by region
-
- United States (3)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Group Appearance index
- 1.00
- Avg. company exit year
- 9
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| ITeos Therapeutics | 20 Jun 2018 | Biotechnology, Health Care, Medical | Early Stage Venture | 75M | United States, Massachusetts, Cambridge |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.